Teva in Europe

Supporting Europe’s medicine supply chain

Teva is located across all major markets in Europe, operating across 28 manufacturing sites and employing over 19,000 people across its operations and commercial arm. We’re the leading generic drug company in Europe, and we also have a strong specialty medicines portfolio focused on central nervous system disorders, respiratory diseases and oncology.

Making Medicines in Europe

“The resilience of Teva’s operation never fails to surprise me”

Meet Romana Santar

Teva Factsheet

Read more

Pharmaceutical Manufacturing Resilience in EU

Read more

COVID-19 puts medicine supply security in Europe's spotlight

Read more

Manufacturing Resilience

Teva in Europe

Teva Europe Manufacturing Resilience

Policy Insights

Executive Summary - Policy Lessons from COVID-19

Read more

Position Paper -
Teva’s views on COVID-19: Policy & Advocacy Commitments

Read more

Policy lessons from COVID-19: Savanta ComRes research report for Teva Pharmaceuticals

Read more

Security of supply

Teva Q&A on security of supply

Read more

Teva position paper on security of supply

Read more

The path towards better security of supply in Europe

Read more